Tahsin ÇOLAK, Mehmet Özgür TÜRKMENOĞLU, Sami BENLİ

Factors influencing anterior/low anterior resection syndrome after rectal or sigmoid resections

Background/aim: Sphincter-preserving surgery is one of the main goals in the treatment of rectal cancer because it improves the quality of life (QoL). However, some patients may experience disrupted symptoms called anterior or low anterior resection syndrome (LARS). This study was designed to evaluate the frequency and influencing factors of LARS in patients who underwent sigmoid or rectal resection. Materials and methods: In this retrospective, clinical study, patients who underwent rectal or sigmoid resection and anastomosis due to any benign and malignant reasons were evaluated in terms of LARS between January 2010 and November 2019 at Medical Faculty Hospital of Mersin University. The frequency and severity of LARS were determined by using a standard scale. Furthermore, influencing factors including lesion localization, operation, the proximity of anastomosis to the anal verge, creation of stoma, chemotherapy, and radiotherapy application were investigated. Results: Out of a total of 550 patients, 276 were included in this study. The major LARS incidence was found as 27.2%. Very low anterior resection (VLAR) (OR = 42.40 (95% CI [11.14–161.36], P < 0.0001), protective ileostomy (OR = 12.83 (95% CI [6.58–25.0], P < 0.0001), end colostomy (OR = 8.55 (95% CI [1.36–53.61], P = 0.022), receiving chemotherapy (OR = 3.08 (95% CI [1.71–5.53], P < 0.0001), and radiotherapy (OR = 2.51 (95% CI [1.38–4.57], P = 0.003) and the ROC analysis showed that creating an anastomosis placed at most 8.5 cm from the anal verge was found to be a major influencing factor on LARS (P < 0.05). Conclusions: LARS may frequently occur in patients who have undergone rectal resection. In this study, the most important factors influencing LARS were found to be the proximity of anastomosis to the anal canal and creating a protective stoma. Receiving chemoradiotherapy also plays an important role in LARS.Key words: Bowel dysfunction, low anterior resection syndrome, rectal cancer, quality of life

PDF

___

1. Glimelius B, Tiret E, Cervantes A, Arnold D. ESMO Guidelines Working Group. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2013; 24 (Suppl. 6): vi81-vi88.
2. Keskinkilic B, Gultekin M, Akarca AS, Ozturk C, Boztas G et al. Turkey Cancer Control Program. Republic of Turkey, Ministry of Health Turkey Public Health Institution Cancer Control Department. 1st ed. Ankara, Turkey: 2016.
3. Van de Velde CJ, Boelens PG, Tanis PJ, Espin E, Mroczkowski P et al. Experts reviews of the multidisciplinary consensus conference colon and rectal cancer 2012: science, opinions and experiences from the experts of surgery. European Journal of Surgical Oncology 2014; 40: 454e468.
4. Emmertsen KJ, Laurberg S. Bowel dysfunction after treatment for rectal cancer. Acta Oncologica 2008; 47: 994e1003.
5. Palmer G, Martling A, Cedermark B, Holm T. A populationbased study on the management and outcome in patients with locally recurrent rectal cancer. Annals of Surgical Oncology 2007; 14: 447-454.
6. Kapiteijn E, Marijnen CAM, Nagtegaal ID, Putter H, Steup WH et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. New England Journal of Medicine 345: 638-646.
7. Ridolfi TJ, Berger N, Ludwig KA. Low anterior resection syndrome: current management and future directions. Clinics in Colon and Rectal Surgery 2016; 29: 239-245. doi: 10.1055/s0036-1584500
8. Emmertsen KJ, Laurberg S. Low anterior resection syndromescore: development and validation of a symptombased scoringsystem for bowel dysfunction after low anterior resection for rectal cancer. Annals of Surgery 2012; 255: 922- 928.
9. Ziv Y, Zbar A, Bar-Shavit Y, Igov I. Low anterior resection syndrome (LARS): cause and effect and reconstructive considerations. Techniques in Coloproctology 2013; 17: 151- 162. doi: 10.1007s10151-012-0909-3
10. Juul T, Ahlberg M, Biondo S, Espin E, Jimenez LM et al. Low anterior resection syndrome and quality of life: an international multicenter study. Diseases of the Colon & Rectum 2014; 57: 585-591. doi: 10.1097/ DCR.0000000000000116
11. Bryant CLC, Lunniss PJ, Knowles CH, Thaha MA, Chan CLH. Anterior resection syndrome. Lancet Oncology 2012; 13: 403- 408. doi: 10.1016/ S1470-2045(12)70236-X
12. Pucciani F. A review on functional results of sphincter-saving surgery for rectal cancer: the anterior resection syndrome. Updates in Surgery 2013; 65: 257-263. doi: 10.1007/s13304- 013-0220-5
13. Jimenez Gomez LM, Espin Basany E, Trenti L, Martí Gallostra M, Sánchez García JL et al. Factors associated with low anterior resection syndrome after surgical treatment of rectal cancer. Colorectal Disease 2017; 20: 195-200. doi: 10.1111/codi.13901
14. Ekkarat P, Boonpipattanapong T, Tantiphlachiva K, Sangkhathat S. Factors determining low anterior resection syndrome after rectal cancer resection: a study in Thai patients. Asian Journal of Surgery 2016; 39: 225-231. doi: 10.1016/j.asjsur.2015.07.003
15. Chen TY, Wiltink LM, Nout RA, Kranenbarg EM, Laurberg S et al. Bowel function 14 years after preoperative short-course radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomized trial. Clinical Colorectal Cancer 2015; 14: 106-114.
16. Sturiale A, Martellucci J, Zurli L, Vaccaro C, Brusciano L et al. Long-term functional follow-up after anterior rectal resection for cancer. International Journal of Colorectal Disease 2017; 32:83.
17. Desnoo L, Faithfull S. A qualitative study of anterior resection syndrome: the experiences of cancer survivors who have undergone resection surgery. European Journal of Cancer Care 2006; 15: 244-251.
18. Wells CI, Vather R, Chu MJ, Robertson JP, Bissett IP. Anterior resection syndrome—a risk factor analysis. Journal of Gastrointestinal Surgery 2015; 19: 350-359.
19. Bregendahl S, Emmertsen KJ, Lous J, Laurberg S. Bowel dysfunction after low anterior resection with and without neoadjuvant therapy for rectalcancer: a population-based crosssectional study. Colorectal 2013; 15(9): 1130-1139.
20. Battersby NJ, Juul T, Christensen P, Janjua AZ, Branagan G, Emmertsen KJ et al. United Kingdom low anterior resection syndrome study group. Predicting the risk of bowel-related qualityof-life impairment after restorative resection for rectal cancer: a multicenter cross-sectional study. Diseases of the Colon & Rectum 2016; 59 (4): 270-280.
21. Bondeven P, Emmertsen KJ, Laurberg S, Kranenbarg EM, Laurberg S et al. Neoadjuvant therapy abolishes the functional benefits of a larger rectal remnant, as measured by magnetic resonance imaging after restorative rectal cancer surgery. European Journal of Surgical Oncology 2015; 41 (11): 1493-1499.
22. Miacci FLC, Guetter CR, Moreira PH, Sartor MC, Savio MC et al. Predictive factors of low anterior resection syndrome following anterior resection of the rectum. Revistado Colegio Brasileiro de Cirurgioes 2020; 46 (6).
23. KupschJ, Jackisch T, Matzel KE, Zimmer J, Schreiber A et al. Outcome of bowel function following anterior resection for rectal cancer-an analysis using the low anterior resection syndrome (LARS) score. International Journal of Colorectal Disease 2018; 33 (6): 787-798. doi: 10.1007/s00384-018-3006-x
24. Croese AD, Zubair ON, Lonie J, Trollope AF, Vangaveti VN et al. Prevalence of low anterior resection syndrome at a regional Australian centre. ANZ Journal of Surgery 2018; 88 (12): E813-E817.
25. Juul T, Elfeki H, Christensen P, Laurberg S, Emmertsen KJ et al. Normative data for the low anterior resection syndrome score (LARS score). Annals of Surgical Oncology 2019; 269 (6): 1124- 1128.
26. Pachler J, Wille-Jorgensen P. Quality of life after rectal resectionfor cancer, with or without permanent colostomy. Cochrane Database of Systematic Reviews 2012; 12: CD004323.